Concepedia

Jaclyn E. McCloskey

JE

Statistics

Publications

9

Citations

355

H-Index

9

Active since

2019

Affiliations

Cornell University(Current)

Molecular Innovations (United States)

Weill Cornell Medicine

DecImmune Therapeutics (United States)

Memorial Sloan Kettering Cancer Center

Jaclyn E. McCloskey is an author at Cornell University specializing in oncology, immunotherapy, and immunology.

Publications per year

2019–2023

9

Publications

9

Manufacturing and preclinical validation of CAR T cells targeting ICAM-1 for advanced thyroid cancer therapy

Yogindra Vedvyas, Jaclyn E. McCloskey, Yanping Yang et al. · Scientific Reports · 2019 · 78 citations · Full text

, , +17

Chimeric Antigen Receptor T Cell Therapy Targeting ICAM-1 in Gastric Cancer

Minkyu Jung, Yanping Yang, Jaclyn E. McCloskey et al. · Molecular Therapy — Oncolytics · 2020 · 62 citations · Full text

, , +17

Bispecific CAR T Cells against EpCAM and Inducible ICAM-1 Overcome Antigen Heterogeneity and Generate Superior Antitumor Responses

Yanping Yang, Jaclyn E. McCloskey, Huan Yang et al. · Cancer Immunology Research · 2021 · 57 citations · Full text

, , +17

PD1 Blockade Enhances ICAM1-Directed CAR T Therapeutic Efficacy in Advanced Thyroid Cancer

Katherine D. Gray, Jaclyn E. McCloskey, Yogindra Vedvyas et al. · Clinical Cancer Research · 2020 · 49 citations · Full text

, , +17

Activation of NPY receptor subtype 1 by [D-His26]NPY is sufficient to prevent development of anxiety and depressive like effects in the single prolonged stress rodent model of PTSD

Chiso Nwokafor, Lidia Serova, Roxanna J. Nahvi et al. · Neuropeptides · 2019 · 31 citations

, , +11

1–5 of 9